ZEB proteins (ZEB1 and ZEB2) are master regulators of EMT, known to repress epithelial markers such as E-cadherin while promoting mesenchymal traits in aggressive breast cancer subtypes17. This evidence concerns the gene ZEB1 and breast cancer.